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Hepatic resection is indicated for primary and secondary malignancies.  Use of a 
low central venous pressure technique is associated with decreased blood loss in these 
cases.  This technique has evolved; central venous catheters and high dose morphine 
are no longer used, and patients are extubated earlier.  The purpose of this study is to 
assess a relationship between these changes and outcomes. 
Central venous pressure has fallen out of favor as an accurate fluid 
measurement.  Central venous catheters are associated with many complications.  
Outcomes in patients undergoing hepatic resection have improved over 20 years at one 
high volume institution. 
Guided by Donabedian’s theory of measuring outcomes, a non-randomized, non-
experimental, retrospective, cohort design was conducted. 
The independent variables were intraoperative insertion of a central venous 
catheter, use of morphine, and time of extubation.  The dependent variables were 
  
superficial and deep wound infections, number and severity of complications. The 
population sample is patients who submitted to partial hepatectomy at Memorial Sloan 
Kettering Cancer Center from 2007-2016. 
Data was obtained from hepatobiliary and anesthesia databases at Memorial 
Sloan Kettering Cancer Center. 
Data of 2518 from a possible 3903 patients were analyzed with chi square, 
univariate, Poisson and multivariate regressions.  Univariate analysis for presence of 
CVC was significant for 90-day mortality (p 0.013).  Use of morphine was significant for 
superficial wound infection (p 0.035), and a decrease in complications (p <.001).  
Amount of morphine was associated with fewer severe complications (p <.001). 
Incidental findings included a relationship between gender, total amount of fluids and 
number of segments resected. 
The significance of CVC with 90-day mortality was eliminated with stepwise 
multivariate regression.  The findings support the change in anesthetic practice with 
clinical significance.  Incidental findings regarding fluids and segments are supported in 
the literature.  Future research should include goal directed fluid therapy and 
investigation of the relationship between gender and outcomes. 
 
 
  1 
 
 
 
 
Chapter 1: Introduction 
 
Introduction 
 
Each year in the United States, about 41,000 people are diagnosed with liver 
cancer, and nearly 29,000 die from the disease (Centers for Disease Control and 
Prevention, 2016).  Liver resection is used to treat primary and secondary malignancies.  
However, there is a high-risk of hemorrhage during this procedure (Kingham et al., 
2015).  Large volumes of intraoperative blood loss are associated with significant 
morbidity (Cunningham et al., 1994)(Heriot & Karanjia, 2002).  A safe and effective 
technique for minimizing blood loss was described by Cunningham et al. (1994) at 
Memorial Sloan Kettering Cancer Center (MSKCC) (Cunningham et al., 1994).  The 
technique involved surgical control of blood inflow to the liver and anesthetic team 
management of fluids and venous capacity to influence blood backflow into the liver 
from the vena cava.  From an anesthesia standpoint, this technique was called a low 
central venous pressure (LCVP) technique. 
Background 
 
LCVP anesthetic technique aided in minimizing blood loss during major liver 
resection (Melendez et al., 1998).  The initial execution of the LCVP technique involved 
the surgical and anesthesia teams working in tandem.  The surgeons controlled blood 
inflow to the liver with the Pringle technique, first described in 1908 by J.H. Pringle 
(Pringle, 1908).  Until the specimen was removed and the patient was hemodynamically 
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stable, the anesthesia team minimized fluids, maintained central venous pressure 
(CVP) at five mmHg or less and positioned the patient in the Trendelenburg (head down 
position).  These maneuvers served to minimize the backflow of blood into the liver from 
the vena cava and venous sinuous network (Cunningham et al., 1994).  Additionally, 
intravenous fentanyl, up to 500 mcgs, morphine, up to 50 mgs, and nitroglycerin 200 
mcg boluses were administered to maintain the CVP at the hemodynamic target.   
CVP monitoring was made possible with the insertion of a central venous 
catheter into the superior vena cava.  First described in 1959 by Hughes and 
MacGovern, and later supported by Wilson et al. (1962), CVP was believed to be an 
accurate and reliable measurement of blood volume (Hughes & Magovern, 1959; 
Wilson, Grow, Demong, Prevedel, & Owens, 1962).  Along with other fluid status 
indicators, such as heart rate and blood pressure, CVP was a critical tool in the 
development of the LCVP technique for liver resections at MSKCC (Cunningham et al., 
1994; Melendez et al., 1998). 
Systematic reviews by Marik, et al.  (E. Marik P. & Cavallazzi, 2013; P. E. Marik, 
Baram, & Vahid, 2008) demonstrated a poor relationship between CVP and blood 
volume, resulting in questioning the veracity of its efficacy, and ultimately initiating a 
change in the LCVP technique in some settings.  Adverse effects of introducing a 
central venous catheter (CVC) are well documented in the literature, and include 
pneumothorax, subclavian artery puncture, subclavian vein laceration, subclavian vein 
stenosis, hemothorax, thrombosis, air embolism, catheter misplacement, cardiac 
dysrhythmia, and site or systemic infection, all of which are associated with increased 
length of stay (Institute for Healthcare Improvement, 2012).   This, combined with the 
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evidence presented in the Marik publications (2008, 2009, 2013) showing low 
correlation between CVP and fluid status, led to a change in practice at MSKCC. 
Since the Melendez et al. (1998) publication, the LCVP technique further evolved 
based on clinically derived evidence that supported change.  The patients were no 
longer given high doses of morphine to lower the CVP in favor of sub lingual 
nitroglycerin, a potent vasodilator (Sand et al., 2014). This practice change led to 
patients who were more likely to be extubated at the end of the case.  Shortly following 
this change, the papers by Marik et al. (2008, 2009, 2013) gained support and the 
practice of using CVCs in this patient population fell out of favor; fluid resuscitation no 
longer required management with central venous access due to decreased blood loss, 
and the idea that CVP was no longer considered a valid measurement of fluid status 
prevailed.  Instead, patients undergoing partial hepatectomy were managed with two 
large bore peripheral intravenous lines and an arterial catheter for continuous blood 
pressure monitoring, in addition to standard monitors.  At that time, dynamic monitoring 
was evolving into a reliable measurement of fluid status.  Once the specimen was 
removed, and hemostasis attained, managing the fluids based on these parameters, in 
part based upon each patient’s unique position on the Frank-Starling curve of fluid 
responsiveness, led to the final change in anesthetic technique.  A primary outcome 
was that patients were receiving less intravenous fluid in the operating room.   
Central venous access for partial hepatectomy was the standard of care at 
MSKCC until around 2010.  The use of CVP monitoring and the LCVP anesthetic 
technique remains the standard of care at many other institutions where liver resections 
are performed. This project will provide a unique opportunity to assess the evolution of 
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the LCVP anesthetic technique and its potential relationship with outcomes for patients 
undergoing partial hepatectomy.   
Problem Statement 
 
Evidence at MSKCC, a high-volume institution for the hepatic surgery, 
demonstrated a substantial decrease in morbidity and mortality rates after a partial 
hepatectomy for cancer between 1993 and 2012. Clinical researchers suggested this 
phenomenon was related to a decrease in number of major resections over time 
(Kingham, et al., 2015); however, one critical aspect of the procedure was not 
assessed, that is the associated simultaneous changes in anesthetic technique that 
occurred.    
Purpose 
 
The purpose of this project was to examine the data from MSKCC with an 
updated time frame (2007-2016) to assess whether there is a relationship between a 
change in anesthetic technique over time and selected outcomes.  The utilization of an 
existing dataset will allow for a systematic study of changes in anesthetic technique that 
will inform best practice in the profession.   
Research Questions and Objectives 
 
 The research question being addressed is as follows: Is there a relationship 
between intraoperative insertion of CVC for the purpose of fluid management in hepatic 
resection and outcomes?  Examination of this question involved the assessment of two 
other milestones in the in the perioperative care of patients receiving the LCVP 
technique at MSKCC.  The first was to examine the effect of a change in practice in the 
use of intraoperative morphine, and the second was to assess the relationship between 
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extubation in the operating room (OR) and outcomes.  The outcomes that were 
measured included complications associated with major organs, the gastrointestinal 
system as well as infection, hemorrhage, and wound breakdown.  The objectives are to 
assess whether: 
• There is a relationship between the insertion of intraoperative CVC and selected 
outcomes in patients undergoing hepatic resection. 
• There is a relationship between the use of morphine for the purpose of lowering 
CVP for hepatic resection and selected outcomes. 
• There is a relationship between extubation in the OR and outcomes in patients 
undergoing hepatic resection. 
Assumptions 
 
 Historically, hepatic resection was associated with morbidity and mortality.  Over 
time, with improved surgical techniques, alternative treatments, and improved patient 
selection, complications associated with this procedure have declined (Correa-Gallego 
et al., 2015; Kingham et al., 2015).  There are other factors that may have had an effect 
on a change in outcomes for patients undergoing hepatic resection.  Over the period of 
time being addressed (2007-2016), there was a change in environment; the operating 
rooms were upgraded, and several anesthetic medications once considered standard 
were eliminated from routine use, including droperidol, thiopental, pancuronium, and 
morphine.  It should also be pointed out that although there was a hepatobiliary 
anesthesia team, individuals who administer anesthesia to patients undergoing hepatic 
resection at MSKCC have varying abilities and experience.  The LCVP technique was 
  6 
expected to be used in these cases.  However, individual practice and clinical judgment 
actions may have differed between anesthesia care providers. 
For the purposes of the planned study, we assumed that the anesthesia care 
provided was equal on both operating room platforms and that a change in medications 
based on evidence and the conduct of individual anesthesia care providers had minimal 
impact on the outcomes being assessed. 
Theoretical Framework 
 Avedis Donabedian described a framework for assessing the quality of care. 
Donabedian used structure, process, and outcomes in his theory measuring the quality 
of healthcare  (Donabedian, 1978).  The model that Donabedian proposed is widely 
accepted in evaluating the quality of health care (Harolds, 2015).  For the purpose of 
this dissertation, the constructs may be considered to be hospital policy/practice 
(structure), whether a CVC was inserted, if patients were extubated in the OR, whether 
morphine was used, how the fluid status was managed (process) and incidence 
complications associated with major organs, the gastrointestinal system as well as 
infection, hemorrhage, wound breakdown and length of stay (outcome). Donabedian 
thought that process had specific importance in measuring quality. Additionally, 
Donabedian believed that focus should be on improving outcomes by way of improving 
process. However, not all improvements in structure and process significantly affect the 
outcome (Harolds, 2015). 
Delineation and Justification of the Research Problem 
 The research problem is a gap in the literature describing the potential 
relationship between utilization of CVC for the purposes of managing fluid status for 
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patients undergoing partial hepatectomy and outcomes.  Use of CVP monitoring in this 
patient population has fallen out of favor at MSKCC.  It was possible to look at the 
hepatobiliary database to assess change in outcomes by comparing cases pre and post 
this change in practice.  It was also be possible to assess the relationship that other 
changes in the LCVP technique over the timeframe being investigated had with 
outcomes.  The investigation looked specifically at three variables: use of morphine, 
insertion and use of CVC for CVP monitoring, and extubation in the OR and their 
relationship with the outcomes of patients who underwent partial hepatectomy at 
MSKCC between 2007 and 2016.  This investigation is important because it sheds light 
on the potential influence on outcomes of an anesthetic technique as it evolved over 
nearly 20 years.  Evidence-based practice is the integration of “the best available 
research evidence with information about patient preferences, clinician skill level, and 
available resources to make decisions about patient care” (American Association of 
Critical-Care Nurses., 1995).  The results of the analysis will add to the knowledge base 
that was reported as a result of the Kingham et al. (2015), investigation.  Additionally, 
the results will either support the change in practice or suggest that the there was no 
relationship between these changes and outcomes.  It is unlikely that the LCVP 
technique in its current form is related to an increase in poor outcomes.  However, this 
result should be considered.  Ultimately, the findings will add to the literature that 
shapes anesthesia practice in this patient population as an important step in the 
ultimate goal of contributing to evidence-based practice. 
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Statement of Hypothesis 
 
 The primary hypothesis is that there is a relationship between presence of an 
intraoperative central venous catheter (CVC) placement and outcomes in patients who 
have undergone partial hepatectomy. Additional hypotheses include other changes to 
the LCVP technique and their relationship with outcomes: amount of time to extubation 
following the procedure, and the use of intraoperative morphine. 
Scope of the Investigation 
 
The project wass a non-randomized, non-experimental, retrospective, cohort 
design.  Data was obtained from patient electronic records in the hospital database as 
reported by the health care team.  Identifying cases was based on date of surgery and 
date billed for intraoperative CVC placement.  Outcomes in the form of presence or 
absence of complication as described in the patient record are outlined in chapter 3 
(Methods). 
Retrospective cohort studies have many of the strengths of prospective cohort 
studies, and they have the advantage of being much less costly and time-consuming  
(Hully, Cummings, Brower, Grady, & Newman, 2013).  Disadvantages of a retrospective 
study design include limited control of the investigator over the approach to sampling 
and follow-up population, and the nature and quality of the baseline measurements.  
The data may be incomplete, inaccurate, or measured in ways that are not ideal for 
answering the research question(s) (Hully et al., 2013).  Challenges associated 
specifically with this project include those associated with retrospective research design; 
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consistency of measurements, other changes in practice, and missing data.  The nature 
of the study should allow for efficient and economic acquisition of the needed data. 
Overview of Remaining Chapters 
 
 This paper is divided into four remaining parts.  Chapter two offers a 
comprehensive review of the literature regarding the use of CVP for the purposes of 
fluid management and the alternatives.  Also included are alternative approaches to 
minimizing blood loss for patients undergoing partial hepatectomy.  Donabedian’s 
theory of evaluating the quality of medical care is also presented as it pertains to the 
proposed research.  Chapter three provides methods and statistical analysis that will be 
utilized to answer the research questions.  Chapter four includes a presentation of the 
study results.  Finally, chapter five will deliver an interpretation and summary of the 
findings.  
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Chapter 2: Review of Literature 
 
 
 
Background 
 Initially designed to test a technique that was described in animal studies, 
Hughes and Magovern (1959) studied 25 thoracic patients to test the efficacy of the 
measuring of the right atrial pressure in predicting changes in intravascular fluid volume 
(Hughes & Magovern, 1959).  The authors concluded that measuring the right atrial 
pressure was an accurate and reliable method for assessing hemodynamics and 
suggested its use in any surgery where a change in hemodynamics may be anticipated 
(Hughes & Magovern, 1959).   
 Following the lead of Hughes and Magovern, Wilson and Grow (1962) described 
indications and a simplified technique to measure what they referred to as central 
venous pressure (Wilson et al., 1962).  Their conclusions emphasized the importance of 
utilization of CVP as a trend and response to fluid therapy and not an isolated, static, or 
predetermined number (Wilson et al., 1962).  Additionally, the authors described their 
first complication associated with accessing the vena cava for the purpose of measuring 
CVP, a fatal pulmonary embolism that developed as an embolus at the site of insertion, 
the saphenous vein.  The technique was altered, accessing the superior vena cava via 
the antecubital fossa and then the subclavian vein.  Following this change, the 
complications described were limited to superficial phlebitis and pneumothoraces 
(Wilson et al., 1962).  The authors made no mention of systemic sepsis and encouraged 
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the practice of monitoring CVP in this manner when indicated despite the reported 
complications.  Other complications associated with, but not mentioned in this early 
study of insertion of central venous access include cardiac arrhythmia, pneumothorax, 
subclavian artery puncture, subclavian vein laceration, subclavian vein stenosis, 
hemothorax, thrombosis, air embolism, site infection, sepsis and catheter misplacement 
(Centers for Disease Control and Prevention., n.d.). 
 In 1994 Cunningham et al. published a paper in which they described an 
anesthetic technique utilizing the measurement of CVP to aid the surgeon in controlling 
intraoperative bleeding during partial hepatectomy.  This LCVP technique, in addition to 
the surgeon’s control of hepatic inflow as first described in 1908 by J. H. Pringle as the 
Pringle technique (Huntington, Royall, & Schmidt, 2014), was reported as a safe and 
effective method that helped to decrease blood loss for these cases (Cunningham et al., 
1994).  The authors analyzed 36 retrospective and 64 prospective cases in which the 
LCVP technique was used during parenchymal resection.  The technique involved 
maintaining CVP below five mmHg with fluid restriction, intravenous morphine and/or 
intravenous nitroglycerin with Trendelenberg position of the bed.  The reported blood 
losses were considered acceptable for such procedures, and the authors concluded that 
the technique was effective (Cunningham et al., 1994). 
 A 1998 retrospective study conducted at Memorial Sloan Kettering Cancer 
Center by Melendez et al. reported that the LCVP technique during hepatic resection 
minimized blood loss and reduced mortality while preserving renal function (Melendez 
et al., 1998).  Over an eight-year period, the authors analyzed data from 496 patients 
assessing outcomes and reported no intraoperative deaths, a median blood loss of 675 
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ml (range 40 ml-9000 ml) and an intraoperative transfusion rate of 33%.  The incidence 
of renal dysfunction was 10%, and when compared to the previously reported 13% 
during standard care, it appeared as if there was an improvement with the utilization of 
the LCVP technique (Edwards & Blumgart, 1987).  Presence of a central venous 
catheter not only allowed for the measurement of CVP, but it also afforded the 
anesthesia care provider the ability to rapidly infuse fluids should the need arise 
(Melendez et al., 1998).  Finally, the authors underscored the necessity of the surgical 
and anesthesia teams working in tandem to facilitate the operative control of, and 
appropriate response to, hemorrhage (Melendez et al., 1998). 
 The goal of decreasing blood loss in the hepatic resection patient population is 
desirable because blood transfusion has been associated with poor outcomes 
(Cunningham et al., 1994; Gruttadauria et al., 2011; Melendez et al., 1998; Stephenson 
et al., 1988).  One study in, particular, looked at patients with metastatic colorectal 
cancer.  Stephenson et al. analyzed data from 55 patients with metastatic colorectal 
cancer who underwent surgical resection of liver disease.  They reported that patients 
who received more than 11 units of red blood cells had a significantly decreased 
disease-free survival rate than those that received less than10 units of blood 
(Stephenson et al., 1988).  In 2011, Gruttadauria et al. examined 90-day outcomes for 
patients who underwent liver resection for malignancy.  The authors looked at 127 
cases between 1999 and 2010 and found an association between intra-operative blood 
transfusion and outcomes.  Patients who received transfusions had longer lengths of 
stay and higher complication rates than those who did not. 
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Current Research 
Central venous pressure monitoring. 
 
Since the inception of using CVP measurement for the purpose of predicting fluid 
status, researchers and practitioners have been encouraged to incorporate the reading 
into their clinical judgment.  In 2007 Magder et al., published findings from 83 intensive 
care unit patients encouraging practitioners to utilize cardiac output measurements 
along with CVP to estimate fluid responsiveness based on the Frank-Starling curve 
(Magder & Bafaqeeh, 2007). 
The most compelling evidence contrary to the practice of measuring CVP to 
predict fluid status comes from Marik et al. (Marik, Baram, & Vahid, 2008; Marik, 
Cavallazzi, Vasu, & Hirani, 2009; Marik  P. & Cavallazzi  R., 2013).  In 2008, Marik et al. 
reviewed 24 studies and reported that there was no correlation between CVP and blood 
volume.  Additionally, the findings failed to find a relationship between CVP and fluid 
responsiveness based on the Frank-Starling Curve (Marik et al., 2008).  In 2009, Marik 
et al. conducted a meta-analysis of 29 studies which included a total of 685 patients.  
The purpose of the analysis was to determine the accuracy of dynamic measurements, 
stroke volume variation (SVV), pulse pressure variation (PPV) and systolic pressure 
variation (SPV).  Additionally, the authors compared these dynamic measurements to 
that of the static CVP measurement.  The authors reported that the dynamic 
measurements accurately, and consistently predicted fluid status.  That is, with the use 
of fluid challenges, these measures predicted increase in stroke volume (SV) and 
therefore, cardiac output (CO) in patients being mechanically ventilated (Marik et al., 
2009).  The authors also reported that the dynamic measurements were significantly 
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more accurate than any other variable reported to date as a predictor of fluid status 
including CVP, left ventricular end-diastolic area index (LVEDAI) measured by 
echocardiography and global end-diastolic volume index (GEDVI) as determined by 
transpulmonary thermodilution (Marik et al., 2009).   
In 2013 Marik et al., updated their meta-analysis exploring the accuracy of using 
CVP as a measurement for fluid management (Marik  P. & Cavallazzi  R., 2013).  The 
authors reviewed 43 studies that included a healthy control, 22 ICU and 20 surgical 
settings.  The aim of the updated analysis was to incorporate recent studies into their 
previous (2013) findings.  The authors stated that despite the rising evidence 
suggesting that CVP is an inaccurate measurement of fluid status, CVP remained a 
popular tool.  The findings suggested that there “are no data to support the widespread 
practice of using central venous pressure to guide fluid therapy,” with the authors 
arguing that the traditional CVP approach should be abandoned (Marik  P. & 
Cavallazzi  R., 2013).  
Contrary to the Marik et al. publications, CVP continues to appear in publications 
as a useful tool for measuring fluid status see.  A 2010 publication, Scales et al. (2010) 
describe the rationale for, process of setting up and interpreting CVP monitoring for the 
purpose of continuing education.  The authors point out several clinical situations in 
which CVP monitoring is appropriate including fluid resuscitation in major trauma, 
cardiac surgery, thoracic surgery, major abdominal surgery, to optimize fluid 
replacement in acute renal failure, to optimize fluid replacement in sepsis and to guide 
fluid replacement in heart failure (Scales, 2010).  Referring to Magder’s 2007 
publication, Scales supports the measurement of CVP for the previously mentioned 
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purposes.  This, despite Magder’s main point that CVP should be used along with other 
measurements such as cardiac output and stroke volume as well as clinical judgment 
(Magder & Bafaqeeh, 2007). 
Alternative trends in fluid status management. 
 
 Dynamic fluid measurements are those measurements that utilize circulatory 
variability during respiration to predict fluid status (Table 1).   
Table 1.  Dynamic Measurements Defined 
Dynamic Measurement Abbreviation Manner of Measurement 
Stroke Volume 
Variation 
SVV Arterial waveform 
SVmax - SVmin / SV mean  
Systolic Pressure 
Variation 
SPV Arterial Waveform 
SBPmax - SBPmin 
Pulse Pressure 
Variation 
PPV Arterial waveform 
SVmax - SVmin / SV mean 
Pleth Variability Index PVI Sp02 waveform 
PPmax−PPmin)/[(PPmax+PPmin)/2 
Note: (“White Paper: Stroke Volume Variation,” n.d.)(Frédéric Michard, 2005)(Cannesson et al., 2008). 
 
Dynamic fluid measurements have gained support of late due to improved 
technology and evidence that these measurements are accurate and consistent 
indicators of fluid status (Marik et al., 2009).  These measurements use the changes in 
arterial and/or oxygen saturation waveform during mechanical, positive pressure, 
ventilation to predict where a patient lies on the Frank-Starling Curve of fluid 
responsiveness (Figure 1). 
Accuracy and consistency were not always the case with dynamic 
measurements.  In 2007 dynamic fluid measurements began to be more thoroughly 
vetted.  As a result, critiques of these measurements were present in publications and 
editorials.  At the time, their accuracy and consistency were variable, with error ranks 
reported to be above 30% (Frédéric Michard, 2007).  This percentage was deemed  
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Figure 1.  Fluid Status as Predicted by the Starling Curve.   
Note: The area indicated by the boxes is the point at which a fluid status no longer increases stroke 
volume and therefore does not improve cardiac output.  Patients in this zone are considered 
unresponsive to fluid. 
 
unacceptable in a publication from Crichtley and Crichtley (1999).  The authors 
evaluated technology, through meta-analysis, which measured cardiac output and 
determined a bias and precision statistic of less than 30% should be considered 
standard.  The authors concluded that limits of agreement and percentage error should 
be reported when conducting such research (Critchley & Critchley, 1999).  Moreover, 
“acceptance of a new technique should rely on limits of agreement of up to +/- 30% 
(Critchley & Critchley, 1999). 
 With technological advancement and improved understanding of the parameters, 
publications began to appear touting the accuracy of the dynamic measurements.  In 
2011, Zochios et al. reported that dynamic measurements were superior to static 
measurements.  The authors reviewed the literature to date and concluded that 
accessibility to these measurements and the evidence of their accuracy made them 
ideal for managing fluid therapy.  At the time, however, evidence pointing to long-term 
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outcomes was limited, and further studies were encouraged (Zochios & Wilkinson, 
2011).  To that end, and with the acknowledgment that there was limited data on the 
impact of dynamic measurement use peri-operatively on outcomes, Lakshmi et al. 
(2016) looked at 60 patients who underwent abdominal surgery with the aim of 
evaluating outcomes.  The subjects were randomized into two groups; one with fluids 
managed with the use of CVP, maintained between 10-12 mmHg and one with fluids 
managed with SVV, where a change of 10% or more was demonstrated after fluid 
challenge.  Outcome measures were length of stay in the intensive care unit (ICU) and 
total hospital stay.  The findings reported a significantly shorter ICU stay in the SVV 
group.  However, despite a shorter total hospital length of stay in the SVV group, the 
numbers were not significant.  Additionally, total fluids administered were lower in the 
SVV group and other measured outcomes, such as use of blood products and colloids 
as well as urine output, remained comparable (Kumar, Rajan, & Baalachandran, 2016). 
 There is one early study that specifically looks at the PPV dynamic measurement 
in patients undergoing hepatic resection.  Solus-Biguenet (2006) evaluated the 
accuracy of PPV, both invasive (radial and pulmonary artery) and non-invasive (infrared 
photoplethysmography and pulse oximetry waveform).  Eight patients undergoing 
hepatic resection were given a total of 54 fluid challenges in the form of 250cc boluses 
of colloid.  Increase in stroke volume index of 10% or more was considered fluid 
responsiveness.  The authors reported that PPV invasive and noninvasive were 
accurate measurements of fluid responsiveness (Solus-Biguenet et al., 2006).  Artifact 
and the lack of real-time readings in the noninvasive PPV measurements underscored 
the need for the technology to evolve. Despite the findings, it is possible that the 
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limitations explain the rationale for dynamic measurements not to be considered 
standard of care at the time. 
Goal-Directed Fluid Therapy (GDFT) 
 
 Fluid management with the aim to optimize cardiac output in an effort to 
maximize oxygen delivery to the organs and tissues has been the topic of many 
research studies (Mythen Monty et al., 2012).  As posed in an editorial that appeared in 
The British Journal of Anaesthesia in 2006, the debate regarding fluid overload and fluid 
restriction has not been settled (Bellamy, 2006).  The author described early 
implementation of efforts to optimize outcomes through fluid therapy and suggested the 
limits to the early trials were inconsistencies in the timing and delivery of fluid 
interventions (Bellamy, 2006).  The trial in question was conducted by Shoemaker et al. 
(1973) at the St. James University Hospital, Leeds, UK.  The authors evaluated the 
hemodynamic patterns of 98 patients who were exposed to major surgical procedures 
and whose conditions were considered life-threatening.  Based on the findings, the 
authors developed what they considered acceptable parameters in cardiac output, 
mean arterial pressure, pulmonary vascular resistance, arterial blood pO2, pH, and 
oxygen consumption that were associated with survival (Shoemaker, Montgomery, 
Kaplan, & Elwyn, 1973). 
 A study conducted by Thacker (2016) evaluated the perioperative fluid 
management and associated outcomes in common surgical cohorts in the United States 
(Thacker, Mountford, Ernst, Krukas, & Mythen, 2016).  The authors suggested that 
there was no current consensus on fluid use or the effects of fluids on outcomes in the 
United States.  A query was made of the Premier Research Database (“Customized 
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healthcare studies from Premier Research Services - Premier, Inc.,” n.d.) for cases 
between January of 2008 and June of 2012.  Data were analyzed for a total of over 
650,000 patients receiving colon, rectal, hip or knee surgery regarding fluid utilization on 
the day of surgery.  They analyzed this information related to length of stay, total costs, 
and postoperative ileus.  High fluid volume was associated with increased length of 
stay, increased total costs and postoperative ileus in the rectal and colon surgery 
cohorts.  The findings also showed low fluid utilization was associated with “worse 
outcomes” (Thacker et al., 2016).  Figure 2 is an illustration that suggests fluid 
optimization leads to optimal outcomes. 
 
Figure 2.  A Comparison of Perioperative Morbidity Risk and Fluid Status. 
 A possible explanation for the lack of utilization of dynamic measures and 
subsequent popularity is suggested by Marik (2009) whose previously mentioned meta-
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analysis suggested that these measurements were only possible with an anesthetized 
and mechanically ventilated patient (Marik et al., 2009). 
 Researchers in other countries endorse the use of goal-directed therapy as a 
sole tool to optimize patient outcomes as well as an integrated part of enhanced 
recovery after surgery protocols as first described by Henrik Kehlet of Denmark (Kehlet, 
1997).  A consensus statement was published in 2009 and updated in 2012 from the 
Enhanced Recovery Partnership; a group put together by the Department of Health in 
England in May of 2009 to promote enhanced recovery protocols designed to improve 
patient outcomes (Mythen Monty et al., 2012).  The statement was published as a set of 
general principles and key recommendations based on the authors’ experience.  The 
authors conceded that “larger, more definitive studies of perioperative fluid management 
and, in particular, the relative contribution of hemodynamic monitoring compared with 
fluid restriction would be welcomed” (Mythen Monty et al., 2012).  They also stipulated 
that such research must be conducted where enhanced recovery protocols are 
embraced.  Another consensus statement was issued in 2015 by the international Fluid 
Optimization Group.  Once again, the statement emphasized that over-hydration and 
under-hydration were deleterious and acknowledged a variability in practice.  The 
group’s intent was to point out the risks and benefits GDFT through evidence to reduce 
variability in practice (Navarro et al., 2015).  The international Fluid Optimization Group 
consisted of 14 researchers from 7 countries.  They conducted a review of 162 fluid 
resuscitation papers from both operative and intensive care unit settings.  The 
consensus statement was the product of 3 years of discussions and analysis of the risks 
and benefits of various methods of fluid management.  The authors concluded that fluid 
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should be managed on an individual basis based on the patients’ level of fluid 
responsiveness and the consensus report included approaches and practical 
recommendations to that end (Navarro et al., 2015). 
In 2017, Michard et al. published a paper evaluating the accuracy of uncalibrated 
dynamic monitors as used for the purpose of GDFT.  The authors suggested that to 
date, methods for assessing dynamic fluid status were predominantly done with 
calibrated pulse contour measurements and/or pulmonary catheters or esophageal 
dopplers (F Michard, Giglio, & Brienza, 2017).  Nineteen studies were evaluated that 
included 2159 patients.  The authors reported a reduction in postoperative morbidity, an 
increase in colloid administration and a decrease in crystalloid administration with the 
use of GDFT.  Total fluid administered, and variability of fluid volume was not influenced 
by the use of GDFT.  Finally, the authors concluded that the use of un-calibrated pulse 
contour techniques was associated with a decrease in postoperative morbidity (F 
Michard et al., 2017). 
 A 2014 publication by Dunki-Jacobs, et al. assessed the accuracy of GDFT in 
hepatic resection patients.  The investigation included 80 patients in two cohorts and 
simultaneously compared CVP to SVV prospectively.  The authors concluded that SVV 
is a safe and effective alternative to CVP measurement during hepatic resection.  It was 
also suggested that SVV offered an option that eliminated risks associated with 
insertion of CVC for the purposes of monitoring CVP (Dunki-Jacobs, Philips, Scoggins, 
McMasters, & Martin, 2014).  A limit to the study, however, is the authors did not 
separate open cases from laparoscopic. 
 
  22 
In 2015, Correa-Gallego published a paper dealing specifically with the use of 
GDFT in uncalibrated pulse contour measurement devices in a population of patients 
undergoing hepatic resection.  The authors conducted a prospective study that included 
136 patients in two cohorts; GDFT and standard perioperative fluid management.  The 
findings suggested that the use of SVV to manage perioperative fluids in patients 
undergoing partial hepatectomy resulted in patients receiving less fluid.  It was also 
reported that there was a relationship between lower intraoperative fluid volumes and a 
decrease in postoperative morbidity for all patients (Correa-Gallego et al., 2015). 
Associated complications 
 Blood transfusion during hepatic resection has become less frequent due to 
improved surgical and anesthetic techniques for hepatic resection (Day et al., 2016).  In 
general, blood transfusion has been associated with poor outcomes, at the forefront of 
which is transmission of communicable disease (Jarnagin et al., 2008).  Of particular 
importance in the cancer patient population is the effect of immunosuppression, which 
has been well documented since the early 1980s when the human immunodeficiency 
disease was first described (Porembka, 2001). 
A study conducted by Gascon (1984) evaluated natural killer cell activity post-
transfusion comparing 50 normal individuals to 79 individuals with disorders requiring 
multiple transfusions over time.  The authors reported that those individuals who 
received blood transfusions had a significantly decreased natural killer cell activity 
proportional to the amount of blood transfused (Gascon, Zoumbos, & Young, 1984).  In 
2003, Kooby et al. examined blood transfusion records and outcome of 1351 patients 
who underwent hepatic resection for metastatic colorectal cancer over a 15 year period 
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at Memorial Sloan Kettering Cancer Center(Kooby et al., 2003).  The authors made a 
point of disclosing the conflicting evidence in the literature regarding the effects of 
transfusion on outcomes in patients with cancer citing eight meta-analyses.  Transfusion 
of any blood products within a 30-day period of the surgical procedure was considered a 
transfusion.  A grading scale of 1-5 was used where grades 3-5 were considered major 
and used for analysis.  Fifty-five percent of the population received a blood product.  
The authors took note that early in the time frame analyzed, transfusion rates were 83% 
and this number dropped by the end of the time frame to 43%.  The authors reported 
that patients who received blood transfusions had longer length of stay and decreased 
survival rate.  The authors concluded that blood conservation methods should be used 
to minimize transfusion of blood products due to the relationship with poor outcomes 
(Kooby et al., 2003). 
 In 2008, Jarnagin et al. conducted an investigation addressing the issue of 
transfusion with acute normovolemic hemodilution (ANH).  The sample included 130 
patients who underwent hepatic resection involving more than three lobes of the liver.  
The target of the intervention arm was a hemoglobin of 8 g/dl.  LCVP anesthetic 
technique was used in both arms of the investigation.  The patients in the ANH arm 
received 50% fewer transfusions when compared to those in the standard care group.  
The authors reported that there was no difference in complication rate between the two 
arms.  Despite the 50% reduction in transfusion requirements in the ANH group when 
compared to standard care, statistical significance was not achieved.  The authors 
attribute this to the low transfusion rate in the standard care arm (25.4%) when 
compared to the anticipated/general population (40%).  A proposed possible reason for 
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this is under powering of the investigation.  The conclusion drawn from the investigation 
was that ANH was a safe and effective method for decreasing likelihood of transfusion 
in patients undergoing major hepatic resection (Jarnagin et al., 2008). 
 Surgical site infection (SSI), is a  common yet preventable complication following 
hepatic resection (Okabayashi et al., 2009).  In 2014, Yang et al. reviewed charts from 
7,388 patients who underwent hepatic resection.  Six hundred ninety-eight patients 
developed SSIs.  Post-operative stays for patients who developed SSI was significantly 
longer (13.6 days compared to 7.2) than those who did not.  The authors identified 
groups from the population who were high risk for developing SSI.  These groups were 
those with hepatolithiasis and those with cirrhosis.  The authors concluded that an effort 
should be made to treat the high-risk groups with caution and to minimize blood loss 
(Yang et al., 2014).  
Adjunct efforts to curb blood loss. 
Antifibrinolytics.  In addition to LCVP, bed position (reverse Trendelenburg) 
and improved surgical techniques, there are other adjunct tools the surgeons utilize to 
minimize perioperative blood loss.  One of these methods is the use of antifibrinolytics.  
One such adjunct is the medication tranexamic acid (TXA), a synthetic derivative of 
lysine that exerts its effects by binding to plasminogen (Carless, Rubens, Anthony, 
O’Connell, & Henry, 2011).  The Clinical Randomization of an Antifibrinolytic in 
Significant Hemorrhage 2 (CRASH 2) trial was conducted beginning in 2005 by 274 
hospitals in 40 countries.  Patients were enrolled based on the uncertainty principle, that 
is if the responsible health care provider was uncertain as to whether or not to treat with 
TXA.  Participants and health care providers were blinded to the treatment arm, TXA or 
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placebo.  A total of10,060 TXA and 10,067 placebo recipients were analyzed.  The 
results of the study revealed that early administration of TXA to individuals at risk of 
significant blood loss was associated with reduced risk of death from hemorrhage.  
Additionally, all-cause mortality was significantly (32%) reduced with TXA.  The authors 
suggested the findings support the use of TXA in a wide range of health care settings, 
and safely reduced the risk of death in bleeding trauma patients (Williams-Johnson, 
McDonald, Strachan, & Williams, 2010). 
 The use of TXA in hepatic resection is not well documented in the literature.  In 
2006, Wu et al. conducted a double-blind randomized trial with 214 participants who 
underwent hepatic resection.  One hundred eight participants received TXA, and one 
hundred six received placebo.  The authors reported that operative blood loss was 
reduced and small vessel venous bleeding could be controlled with compression and 
not suturing due to the effect of TXA (Wu et al., 2006).  The authors concluded with a 
suggestion that blood transfusion during hepatic resection could become a rare 
occurrence with the assistance of TXA (Wu et al., 2006). 
 In a study conducted by Karanicolas et al. (2016) a sample of 18 was divided into 
three cohorts to investigate two dosing protocols.  The authors’ aim was to assess the 
impact of TXA on hyperfibrinolysis that occurs due to systemic inflammation or hepatic 
injury during major hepatic resection (Karanicolas et al., 2016).  The authors utilized 
serial blood samples and measured thromboelastography (TEG), coagulation 
components and the concentration of TXA.  The findings were negative for TXA 
influence on levels of TEG and plasmin-antiplasmin complex.  The authors suggested 
that local parenchymal surface fibrinolysis may be affected by TXA and further studies 
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should be conducted to assess such an impact at a cellular level (Karanicolas et al., 
2016). 
Topical agents.  Another adjunct to control bleeding are topical agents which 
include fibrin sealants, collagen, gelatin and cellulose sponges and/or a combination of 
products.  As described in an overview of hemostasis techniques for patients 
undergoing hepatic resection, fibrin sealants have mixed support.  Berrevoet (2007) 
suggested that fibrin sealant enhances clot formation but may also aid in minimizing 
post-operative biliary leaks and fistula formation (Berrevoet & de Hemptinne, 2007).  In 
2002, Henry et al. evaluated 12 trials where fibrin sealants were utilized to control 
intraoperative bleeding.  The authors conceded that the trials that met inclusion criteria 
were small and of poor methodological design.  Their results suggested that fibrin 
sealants were effective in controlling blood loss but large-scale trials were encouraged 
(Carless et al., 2011).  Figueras et al. (2007) published a paper evaluating the efficacy 
of fibrin sealants on hemorrhage, biliary leakage and post-operative complications in 
patients who underwent partial hepatectomy.  The sample size included 300 patients 
who were randomized to receive topical fibrin intraoperatively or standard care control.  
The authors reported that there were no differences between the groups regarding 
transfusions.  There were no differences between the groups in leakage rates as well.  
Additionally, there were no differences in the incidence of biliary fistula and/or mortality.  
The publication concluded with a suggestion that the use of fibrin sealant for the 
purpose of minimizing blood loss, leakage and improving post-operative outcomes was 
unjustified and that discontinuing the practice of using such methods for the stated 
purposes would be a cost-saving maneuver (Figueras et al., 2007). 
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Other blood component factors.  Recombinant factor VIIa has also been 
investigated as a prophylactic drug to minimize blood loss during partial hepatectomy.  
Alkozai et al. (2008) concluded that this drug might better serve as a “rescue therapy” 
for use in uncontrolled bleeding when other methods have failed (Alkozai, Lisman, & 
Porte, 2009). 
Rationale for changes in the LCVP technique over time 
 
 Since first developed as an anesthetic technique in the early 1990s at Memorial 
Sloan Kettering Cancer Center and described by Cunningham et al. (1994), the LCVP 
technique has evolved in response to evidence-based changes in practice over time.  In 
the early 2000s, the use of heavy narcotics (up to 30mg of intravenous morphine and 
500mcg of intravenous fentanyl) for the purposes of lowering CVP were abandoned in 
favor of the use of intravenous and then sublingual nitroglycerin.  This change in 
technique allowed for the patients to be extubated before arrival in the post-anesthesia 
care unit (PACU).  A 2009 publication from Hammoud et al., evaluated 228 patients who 
underwent major orthopedic surgery.  The authors explored the synergistic effects of 
morphine with other adjunct pain medications and concluded that 20 mg of morphine or 
more administered in the immediate postoperative period was associated with an 
increase in sedation and delay in extubation (Hammoud et al., 2009).  Application of this 
knowledge to other specialties such as hepatobiliary patients has improved outcomes in 
the form of minimizing time spent on a mechanical ventilator, which in and of itself is 
associated with poor outcomes.  A study by Nobili et al. (2012) evaluated 555 patients 
who underwent hepatic resection.  The purpose of their study was to assess for risk 
factors associated with postoperative pulmonary complications.  The retrospective data 
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were analyzed with particular attention to poor outcomes regarding pleural effusion, 
pneumonia and pulmonary embolism.  The authors suggested that postoperative 
pulmonary complications were associated prolonged hospital stay and more frequent 
intensive care unit admissions (Nobili et al., 2012).  To this end, decreasing the time a 
patient is mechanically ventilated may improve outcomes by minimizing risk factors 
associated with postoperative pulmonary complications. 
 Alternative approaches to pain control include incisional injection of local 
anesthetics, transverse abdominus plane (TAP) blocks and epidural catheter injection of 
morphine and local anesthetics.  A recent study by Aloia, et al. (2017) included 146 
patients who underwent hepatic resection and compared thoracic epidural analgesia 
(TEA) with intravenous pain-controlled analgesia.  The authors concluded that TEA was 
more effective than intravenous controlled analgesia, the patients required less 
intravenous morphine, had superior pain control and demonstrated comparable length 
of stay (Aloia et al., 2017). 
 Alternatively, surgeons may opt to perform hepatic resections laparoscopically.  
Benefits of laparoscopic liver resection (LLR) have been described to include decreased 
intraoperative bleeding, transfusion requirements, as well as lowering incidence of 
postoperative ascites (Egger et al., 2017).  In 2017, Egger et al. published an overview 
of the preoperative, perioperative and postoperative anesthetic consideration for 
patients who LLR has been deemed appropriate.  The popularity of performing LLR has 
increased, however as the authors point out, the learning curve is steep, and selection 
of appropriate candidates is imperative (Egger et al., 2017). 
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 Enhanced recovery after surgery (ERAS) protocols have become popular of late.  
ERAS is a comprehensive pathway that surgical patients are put on to optimize 
treatments and minimize poor outcomes related to said treatments.  They capitalize on 
preemptive treatment of potential side effects surgery and anesthesia, early ambulation 
and discharge.  In the oncologic population, these goals help to minimize the 
interruption of cancer treatment when surgical intervention is necessary.  In 2015, a 
study conducted by Day, et al. at MD Anderson compared 75 patients who were on an 
ERAS pathway with 43 patients who were treated with standard care.  The pathways 
included patient education, reduction in use of narcotics during anesthesia and for 
analgesia, early return to normal diet, fluid restriction, early ambulation and limited use 
of drains.  The patients rated severity of life interference preoperatively and 
postoperatively.  The authors suggested that use of ERAS pathways in patients 
undergoing hepatic resection was beneficial in that it allowed for improved patient 
satisfaction and early return to oncological treatments (Day et al., 2015) 
Evolution of LVCP at MSKCC. 
 
 Around 2008, the LCVP technique became somewhat of a misnomer because 
CVP was phasing out as a valued measurement of fluid status.  Central venous 
catheters were no longer routinely placed in patients undergoing partial hepatectomy.  
At that time there was a move to dynamic measurements, and this modification to the 
LCVP technique was described and previously presented in this paper as the study 
conducted by Correa-Gallego in 2015 (Correa-Gallego et al., 2015).  
 Kingham et al. (2014), published a paper looking at three phases in time 
regarding the outcomes of patients undergoing partial hepatectomy at Memorial Sloan 
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Kettering Cancer Center.  The authors evaluated 4152 patients and assessed the 
changes in morbidity and mortality from 1993 to 2012 at one institution.  The authors 
reported that morbidity and mortality had decreased.  They attributed the improved 
outcomes to changes in surgical technique, prevention of SSI and increased alternative 
techniques for treating liver cancer  (Kingham et al., 2015).  The authors failed to 
account for change in anesthetic technique, specifically, early extubation, limited use of 
central venous catheters and change in fluid management. 
Application of Theory 
 
Avedis Donabedian described a framework for assessing the quality of care 
using the linear relationship between structure, process, and outcomes. 
(Donabedian, 1978).  These constructs allow investigators to clearly describe what is 
being assessed and their influences can be exerted in multiple directions.  Additionally, 
Donabedian’s theory affords an explanation of relationships.  These are two qualities 
considered standard elements in theory  (Goes & Simon, 2012).  According to Goes and 
Simon (2011), theories exist as a belief regarding reality.  A theory’s purpose is to 
“describe, explain, predict, or understand human or social phenomena in a variety of 
contexts (Goes & Simon, 2012) 
Constructs. 
 
Donabedian’s first approach to assessing quality of health care focuses on 
structure.  This is the setting in which the care is delivered.  Here he is focusing on 
“adequacy of facilities and equipment; the qualifications of medical staff and their 
organization; the administrative structure and operations of programs and institutions 
providing care; fiscal organization and the like” (Donabedian, 1978).  Assumptions such 
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as given proper settings and instrumentalities, good medical care will follow, must be 
avoided (Donabedian, 1978).  Donabedian conceded that a major limitation when 
assessing structure is that the relationship between structure and process and structure 
and outcome, is often not well established (Donabedian, 1978). 
Donabedian also looked at assessing the process of care itself.  This is the 
application of medical knowledge to medical care or whether medicine is being properly 
practiced.  Russell (1998) points out that it is important to determine whether the 
process is fully documented and standardized because, “if it is not, it will not be possible 
to say which components are the cause of any variations in outcomes, and therefore 
attribution remains approximate and an unsound basis for changing the provision of 
care”(Russell, 1998).  This is in keeping with Goes & Martin’s (2012) assessment of 
standards for evaluating theory and their emphasis on internal and external consistency. 
 Finally, Donabedian examined outcomes.  The advantages of measuring 
outcomes is that validity of outcome as the criterion of quality is seldom questioned.  
There is no doubt about the stability and validity of the values of recovery, restoration 
and survival in most situations (and most cultures but not in all).  Finally, outcomes tend 
to be concrete, amenable to more precise measurement  (Donabedian, 1978).   
Limits to outcome measurements include the possibility that a particular outcome 
may be irrelevant, such as when survival is chosen as a criterion of success in a 
situation which is not fatal but is likely to produce suboptimal heal or crippling 
conditions.  Many factors other than medical care may influence outcomes, and they 
must be held constant if valid conclusions are to be drawn 
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In some cases, long periods of time (decades) must elapse before relevant outcomes 
manifest.  Results may not be available when they are needed for appraisal, and the 
problems of maintaining comparability are greatly magnified  (Donabedian, 1978).  An 
example of a linear relationship between the constructs of Donabedian’s theory is 
illustrated in Figure 3. 
 
Figure 3. The Constructs of Donabedian’s Theory  (Shi & Singh, 2015). 
 Greater specificity of variables allows the research team to exercise much 
greater control over what dimensions of care require emphasis and what the acceptable 
standards are (Donabedian, 1978).  This is also an element of a theory that Goes and 
Simon (2012) refer to as ‘simplicity’  (Goes & Simon, 2012). 
Measurement 
 
The Donabedian theory also takes into account reliability of assessments.  The 
major mechanism for achieving higher levels of reliability is the detailed specification of 
criteria, standards, and procedures used for the assessment of care (Donabedian, 
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1978).  Consistency between assessors is important as is consistency with one 
assessor over time.  Reliability can also be improved with reproducibility. 
Donabedian believed that process elements could be used as indicators of 
quality only if there is a valid relationship between those elements and desired 
outcomes(Donabedian, 1978).  For instance, it is important to account for other factors 
that may be related to the outcome of interest so as not to skew the findings.  In other 
words, establishing a relationship between the two variables as independent improves 
validity.  Donabedian also stated that specific outcomes could be used as indicators of 
the quality of care only to the extent that there is a valid relation between the two.  In 
effect, validity resides not in the choice of the elements of process or the outcome but in 
what is known about their relationship (Donabedian, 1978).   
Donabedian’s theory applies to this dissertation in a fashion which overtly utilizes 
two of the constructs; process (utilization of central venous catheter) and outcome 
(complications).  This example shown in figure 4 as actual delivery of health care and 
the relationship, or impact it has on final outcomes.  The application of Donabedian’s 
theory does not necessitate the use of all three constructs, structure, process and 
outcome.  However, it could be argued that for this project MSKCC is a structure 
concept where the data is being generated, and therefore, all three constructs are in 
play as shown in Figure 4. 
Using the Donabedian theory to address this issue also demonstrates this 
theory’s ability to show practicality as well as acuity, the final two standards mentioned 
by Goes and Simon (2012).  In doing so, one will be able to provide insight into an 
otherwise complex issue with real-world application  (Goes & Simon, 2012). 
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Figure 4. Application of Donabedian Constructs. 
Hypotheses 
 
In this study, there are five hypotheses under investigation based on the 
Donabedian theory.  The constructs of structure, process and outcome are implemented 
in the form of the proposition that changes in patient care lead to changes in patient 
outcomes. 
• Hypothesis one (H1):  There is a relationship between the use of a central venous 
catheter and patient outcomes for patients who have undergone partial 
hepatectomy. 
• Hypothesis two (H2):  There is a relationship between time of extubation following 
partial hepatectomy and patient outcomes. 
• Hypothesis three (H3):  There is a relationship between use of intraoperative 
morphine for the purposes of LCVP and outcomes for patients who have 
undergone partial hepatectomy. 
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A review of the literature shows no research addressing whether there is a relationship 
between the evolution of LCVP technique and outcomes for patients undergoing hepatic 
resection. 
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Chapter 3: Methods 
 
 
 
 Guided by Donabedian’s theory assessing the quality of health care, this chapter 
presents the methods and analytical approach to addressing the core hypothesis and 
research question regarding a relationship between presence of a central venous 
catheter in patients undergoing partial hepatectomy at a single, high volume institution 
and outcomes.  
The stated objectives of this research project are to assess whether there is a 
relationship between a) insertion of intraoperative CVC and selected outcomes in 
patients undergoing hepatic resection, b) the use of morphine for the purpose of 
lowering CVP for hepatic resection and selected outcomes, and c) extubation in the OR 
and outcomes in patients undergoing hepatic resection.  A summary of the purpose, 
objectives, and research hypotheses is provided in Table 2. 
Methodology/Approach 
 
 This project is a non-randomized, non-experimental, retrospective, cohort design.  
Retrospective designs involve collecting data about an outcome in the present and then 
looking back in time for possible relationships (Polit, 2006).  
Research Design 
 
 The independent variables are presence of CVC and use of morphine for the 
purposes of LCVP anesthetic technique and extubation of patients in the OR for 
patients undergoing hepatic resection. The dependent variables are selected outcomes  
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Table 2.  Summary of Purpose, Objectives and Hypotheses 
Purpose Objectives Research Hypotheses 
to examine the data from 
MSKCC with an updated 
time frame (2006-2016) in 
an effort to clarify if change 
in anesthetic technique 
over time had an impact on 
selected outcomes 
to assess whether there is 
a relationship between 
insertion of intraoperative 
CVC and selected 
outcomes in patients 
undergoing hepatic 
resection 
H1 There is a relationship 
between the use of a 
central venous catheters 
and patient outcomes 
 To assess whether there is 
a relationship between the 
use of morphine for the 
purpose of lowering CVP 
for hepatic resection has 
and selected outcomes. 
 
(H2):  There is a 
relationship between use 
of intraoperative morphine 
for the purposes of LCVP 
and patient outcomes 
  (H3):  There is a 
relationship between time 
of extubation at the end of 
the procedure and patient 
outcomes 
 
and are included in Table 3.  More than one complication in the same category will only 
be counted once.   
Demographic data will also be collected.  These items are included in Table 4. 
Surgical procedures are delineated in Table 5. 
 
All patients will have undergone general anesthesia.  All medications 
administered as well as all captured vital signs will be included for analysis.  
Other data collected will be intravenous crystalloid, intravenous colloid, intravenous 
blood products, urine output, estimated blood loss, and adjunct coagulation products 
such as topical antifibrinolytics. 
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Table 3.  Postoperative Complications 
Organ System Specific Complication 
Liver/biliary  
 Hepatic insufficiency/failure 
 Sterile perihepatic fluid collections 
 Biliary Stricture 
 Cholangitis 
Pulmonary  
 Pleural effusion 
 Atelectasis 
 Respiratory insufficiency/failure 
 Pulmonary embolism 
Cardiovascular  
 Arrhythmia 
 Deep vein thrombosis 
 Congestive heart failure 
 Angina pectoris/myocardial infarction 
 Cardiac arrest 
 Stroke/TIA/CNS hemorrhage 
 Pericarditis/pericardial effusion 
Genitourinary  
 Renal insufficiency 
 Urinary retention 
Gastrointestinal  
 Ileus 
 Bowel obstruction 
 Gastrointestinal hemorrhage 
 Colitis (includes C. diff) 
 Bowel perforation 
Infection   
     Abdominal Wound infection 
 Perihepatic abcess 
 Bile leak/biloma 
     Nonabdominal  
 Sepsis/bacteremia 
 Urinary tract infection 
 Pneumonia 
Miscellaneous  
 Perioperative hemorrhage 
 Delirium 
 Wound breakdown/fascial dehiscence 
 Ascites 
 Pump dysfunction 
 Multisystem organ failure 
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Table 4. Demographic Data 
Variable Measurement 
Age Years 
         
Sex M/F 
  
Comorbidity %  1, 2, >/= 3 
  
 
Table 5.  Surgical Procedures 
Procedure  
Major hepatectomy >/= 3 segments 
Segments resected n 
Left hepatectomy  
Left trisesectionectomy  
Right hepatectomy  
Posterior sectionectomy  
Right trisectionectomy  
Resection combined with 
ablation 
 
 
Selection of Subjects 
 
 The population under investigation is patients who have undergone partial 
hepatectomy.  The number of cases in the sample was be limited to the number of 
cases performed at MSKCC.  MSKCC surgeons perform nearly such 400 cases 
annually.  Therefore, the sample size wass expected to be 400 per year over the 10-
year period and all cases between 2007 and 2016 meeting inclusion criteria were 
analyzed.  The investigation will took place at MSKCC.   
The rationale for the sample population is convenience as the PI is employed at 
MSKCC and this institution is does a high volume of hepatic resections annually. 
Inclusion and exclusion criteria are described in Table 6. 
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Table 6.  Inclusion and Exclusion Criteria 
Inclusion Criteria Exclusion Criteria 
18 years of age and older <18 years of age 
Undergoing partial hepatectomy at 
MSKCC 
Infection/sepsis at time of admission 
Admission for other reason than partial 
hepatectomy 
 Previous hepatic resection 
  
 
Instrumentation 
Tests and measures were that of standard practice at MSKCC.  Aforementioned 
variables were recorded in the patient’s electronic medical record as described in Table 
7. 
 
Table 7.  Description of Instrumentation 
MSKCC 
Information comes from Optime/EPIC 
Vital Signs and all intraoperative information are captured on:GE B850 Monitor -
>GE Unity ->Excel BedmasterEx ->Rhapsody HL7 interface engine -> EPIC 
All laboratory values are captured in Allscripts CIS 
All assessments are obtained from Optime EMR 
 
Data Collection and Recording 
 
 Data was a compilation of documents regarding patient hospital stay from 
admission forms to intraoperative records and EMR which includes official discharge 
date.  The information was recorded by a variety of health care professionals involved in 
the patients care in Optime/Epic at MSKCC. 
Data collection was from January 2006 through December of 2016.   Once successfully 
navigating the internal review board of MSKCC and VCUMC to obtain permission to 
access the database, the data was queried.  Data was housed in CAISIS which is a 
surgery-run data warehouse. The research team abstracts and entered the surgical 
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information into CAISIS and the data manager queried it out for the investigators as 
requested. It was queried from Access and exported it into Microsoft’s excel. Data 
managers entered the information in dataline requests to internal database or ran 
separate queries through a dissimilarity analysis and representation (DARwin) program 
for windows to try to fill in the blanks for missing data. If those failed, the investigative 
team performed chart review for any missing data. 
Data Processing and Analysis 
 
Summary statistics were reported as median and interquartile range (IQR) for 
continuous variables. Categorical variables were reported as percentages. 
Comparisons were made with t-tests or Mann-Whitney tests depending on type of 
distribution for continuous variables. Categorical variables were compared with chi-
squared or Fisher’s exact test, based on number of observations. Univariate and 
multivariate analyses used logistic regression. Comparisons with complications were 
analyzed using Poisson regression.  All reported p values will be 2-tailed and those < 
0.05 are considered significant.  Data analysis was performed with IBM’s SPSS version 
24. 
Findings were written in prose and included tables for values that show signs of 
significance to better illustrate the relationships. 
Methodological Assumptions 
 
 All methods of measurement were considered valid.  Additionally, health care 
professionals were assumed to be equally competent and proficient in delivering health 
care to the sample population under investigation. Finally, was assumed that infection 
  42 
rates/complication rates at any given time do not influence infection rates/complications 
from any other given time. 
Limitations 
 
Disadvantages of a retrospective study design include limited control of the 
investigator over the approach to sampling and follow-up population, and the nature and 
quality of the baseline measurements.  The largest disadvantage of this investigation is 
that it is not possible to infer causality from the results.  Additionally, the data may be 
incomplete, inaccurate, or measured in ways that are not ideal for answering the 
research question(s) (Hully et al., 2013).  It may be assumed that the individuals who 
collected the data were equal however, the ability to rule out personal bias based on 
experience and its influence on measurements cannot be ignored.   
Summary 
 
 Chapter three included a discussion of the methods utilized in this non-
randomized, non-experimental, retrospective, cohort study.  A description of the study 
plan to assess whether there is a relationship between a) insertion of intraoperative 
CVC, b) the use of morphine for the purpose of lowering CVP c) the extubation of the 
patient in the OR and outcomes in patients undergoing hepatic resection was described.  
Also provided was information regarding sampling methods, variables, data collection 
and management, statistical analysis, assumptions and limitations of the study.   
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Chapter 4: Results 
 
 
 
 The low central venous pressure (LCVP) technique, first described in 1994 by 
Cunningham, et al (Cunningham et al., 1994) at Memorial Sloan Kettering Cancer 
Center has evolved over these last 20 years.  The purpose of this research was to 
explore effects of several changes to the LCVP technique on patients undergoing 
hepatic resection.  In this study, relationships between use of morphine, insertion of 
central venous catheter (CVC) and total fluids administered, and outcomes were 
explored. 
 A non-randomized, non-experimental, retrospective, cohort design was used to 
meet three study objectives: to assess whether there is a relationship between a) 
insertion of intraoperative CVC and selected outcomes in patients undergoing hepatic 
resection, b) the use of morphine for the purpose of lowering CVP for hepatic resection 
and selected outcomes, and c) extubation of the patient in the OR and outcomes in 
patients undergoing hepatic resection.   
 Data allocation and preparation and statistical analysis exploring the relationship 
between the variables is described in chapter four.  The chapter begins with a 
description of the variables and the process of cleaning the data for analysis.  A 
summary of the statistical results regarding the individual objectives follows.   
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Data 
Review of data acquisition 
 Following IRB approval from VCU and MSKCC, data was obtained from the 
January 1, 2007 through December 31, 2016.  A total of 3903 (n = 3903) patients were 
initially to be included in the analysis.  The anesthesiology database included 2958 
cases and after cases were eliminated due to missing data the final sample size was 
2518. 
Data preparation and cleaning. 
 
 Data was combined by the primary investigator using an Excel spreadsheet.  
Data was inspected for accuracy of input and assigned as either binary or continuous 
for the purposes of analysis. 
 All variables were assessed for normality of skewness and kurtosis, and 
distribution.  Additionally, outliers were identified, and assumptions assessed.   
All data was obtained from the hepatobiliary and anesthesiology databases 
located at MSKCC.  The data dated from January of 2006 to December of 2016.  
Figure 5 describes the impact of cleaning the data in preparation for analysis on the 
sample size. 
 
Figure 5. Impact of Data Cleaning. 
 
n = 2518Hepatobiliary Database n=3903
Anesthesiology Database
n = 2958 -440 (Missing 
Data)
  45 
Data Analysis 
 The following section describes variables in the final analysis.  The data of 2518 
cases provided evidence regarding the research hypotheses being tested (H1-H3).  The 
hypotheses address relationships between presence of a CVC, use of morphine, and 
extubation, on postoperative infections, and other complications in patients undergoing 
hepatic resection.  Table 8 includes the definitions of the variable abbreviations as they 
appear in the analysis.   
Table 8. Variable Abbreviation Definitions. 
DOS Date of Surgery 
PROC_NAME Procedure Name 
FEMALE Female 
AGE Age 
EXT Extubated in OR 
TOTAL Total Fluids 
CVP Central Venous Line 
MS Morphine Sulfate 
AMT Morphine Sulfate Amount 
MORT90D 90 Day Mortality 
NUM_COMP Number of Complications 
NUM_SEVERE_COMP Number of Severe Complications 
WOUND_INF Superficial Wound Infection 
INT_ABD_INF_ABC Intra-Abdominal Infection or Abcess 
NUMBER OF CO MORB Number of Comorbidities 
TOT NUM SEGS Total Number of Segments 
LAP Laparoscopic 
  
 
Univariate regression was used to assess whether specific relationships exist.  
Mulitvariate regression determined overall influence on outcomes.  Additionally, a 
Poisson regression was used to assess the number of times that an event occurred in a 
specific interval of time. 
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Table 9.  Descriptive Statistics 
Continuous: Median (Min, Max)  
Categorical: N (%) 
 Overall 
AGE 59 (18, 90) 
TOTAL 2800 (0, 16750) 
UOP 230 (0, 4000) 
EBL 300 (0, 7800) 
TOT_PROCEDURE_TIME 228 (1, 1136) 
FEMALE  
0 1285 (51) 
1 1233 (49) 
EXT  
0 718 (28.5) 
1 1800 (71.5) 
EPI  
0 2345 (93.1) 
1 173 (6.9) 
CVP  
0 2107 (83.7) 
1 411 (16.3) 
MS  
0 1881 (74.7) 
1 637 (25.3) 
MORT90D  
0 2482 (98.6) 
1 36 (1.4) 
NUM_COMP  
0 1608 (63.9) 
1 504 (20) 
2 262 (10.4) 
3 81 (3.2) 
4 31 (1.2) 
5 20 (0.8) 
Table 9. Continued 
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6 2 (0.1) 
7 4 (0.2) 
8 1 (0) 
9 1 (0) 
10 2 (0.1) 
11 2 (0.1) 
NUM_SEVERE_COMP  
0 2073 (82.3) 
1 341 (13.5) 
2 76 (3) 
3 21 (0.8) 
4 5 (0.2) 
6 1 (0) 
7 1 (0) 
MAX_COMP_GRADE  
0 1608 (63.9) 
1 159 (6.3) 
2 306 (12.2) 
3 408 (16.2) 
4 13 (0.5) 
5 24 (1) 
WOUND_INF  
0 2436 (96.7) 
1 82 (3.3) 
INT_ABD_INF_ABC  
0 2370 (94.1) 
1 148 (5.9) 
BENIGN.0.MALIGNANT.1.  
0 74 (2.9) 
1 2444 (97.1) 
NUMBER.OF.CO.MORB  
1 2277 (90.4) 
2 215 (8.5) 
3 25 (1) 
4 1 (0) 
Table 9. Continued 
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NUMBER OF SEGMENTS   
<3 1624 (64.5) 
>=3 894 (35.5) 
LAP  
0 2323 (92.3) 
1 195 (7.7) 
 
included.  After data cleaning a total of 2518 cases were analyzed of 3903 possible 
cases.  The inability to include all cases is a known limitation of studies of this nature 
(Polit, 2006). 
Descriptive Statistics 
 Descriptive statistics on the variables investigated in this study are presented in 
Table 9.  For each, median, minimum and maximum/or percentage numbers are  
Hypothesis Testing 
 Data was confirmed to not be in violation of assumptions of normality, linearity, 
homoscedasticity.  Following this, the three hypotheses were tested. 
Hypothesis one (H1) 
 Hypothesis one (H1) assessed for a relationship between the use of central 
venous catheters and outcomes for patients undergoing hepatic resection.  Results for 
presence of CVC are shown in table 10.   
• Hypothesis one (H1): There is a relationship between the use of central venous 
catheters and outcomes in patients undergoing hepatic resection. 
Hypothesis one was tested by univariate logistic regression and showed a 15%, 
odds ratio 1.15 (0.63-1.98, CI 95%) increase in wound infection, and a 10%, odds ratio 
1.10 (0.7-1.67, CI 95%) increase in deep wound infection or abscess with the presence  
Table 9. Continued 
Table 9. Continued 
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Table 10. Results for Presence of Central Venous Catheter 
Univariate Logistic Wound 
INF 
Odds Ratio (95% CI) p-value 
CVC 1.15 (0.63-1.98) 0.624 
   
Univariate Logistic Int Abd Inf 
or Abc 
  
CVC 1.1 (0.7-1.59) 0.673 
   
Univariate Logistic 90D 
Mortality 
  
CVC 3.34 (1.66-6.52) <.001 
   
Poisson Regression-Number 
of Complications 
Slope/ Estimates p-value 
No CVC 0.62 .122 
CVC 0.69  
   
Poisson Regression-Number 
of Severe Complications 
  
No CVC 0.22 0.003 
CVC 0.30  
 
of a central venous catheter.  However, these results appear to be clinically 
significant, yet were not statistically significant with p-values of 0.624 and 0.673 
respectively. 
There was a significant relationship between use of central venous catheters and 
90day mortality.  An odds ratio of 3.34 (95% CI, 1.66-6.52) was demonstrated with 
univariate logistical regression (p-value <.001, CI 95%). 
A Poisson regression analysis showed significance in central venous catheter 
(Slope/Estimate 0.22) versus no central venous catheter (Slope/Estimate 0.30) with a p-
value of .003 in incidence of severe complications but no significant difference in 
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complications over all.  Significant findings from univariate regression were included in a 
stepwise multivariate regression, all were eliminated in that process. 
Hypothesis two (H2) 
 Hypothesis two (H2) assessed for a relationship between the time of extubation 
and outcomes for patients undergoing hepatic resection.  Results for extubation are 
shown in Table 11.   
Table 11.  Results for Extubation 
Univariate Logistic Wound 
INF 
Odds Ratio (95% CI) p-value 
Extubated in OR 0.68 (0.43-1.09) 0.102 
   
Univariate Logistic Int Abd 
Inf or Abc 
  
Extubated in OR 0.85 (0.6-1.22) 0.368 
   
Univariate Logistic 90D 
Mortality 
  
Extubated in OR 1.2 (0.58-2.71) 0.638 
   
Poisson Regression-
Number of Complications 
Slope/ Estimates p-value 
Not Extubated in OR 0.58  
Extubated in OR 0.66 0.021 
   
Poisson Regression-
Number of Severe 
Complications 
  
Not Extubated in OR 0.21  
Extubated in OR 0.24 0.173 
 
• Hypothesis two (H2): There is a relationship between the time of extubation and 
outcomes in patients undergoing hepatic resection. 
 Hypothesis two was tested by univariate logistic regression and showed a 32%, 
odds ratio 0.68 (0.43-1.09, CI 95%) decrease in incidence in superficial wound infection 
and a 15%, odds ratio 0.85 (0.6-1.22, CI 95%) decrease in deep wound infection or 
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abscess.  Again, these results may be clinically significant but do not meet criteria for 
statistical significance. 
 Ninety-day mortality did not reach significance with a p-value of .638 and showed 
an odds ratio of 1.2 (0.58-2.71) which suggests a 20% increase in 90day mortality 
associated with extubation in the OR.   
 The Poisson regression for any complications shows a p-value of .021 (CI 95%).  
The results show that extubation in the OR was associated with slightly larger incidence 
of complications compared to extubated in the post anesthesia care unit, with 
slope/estimates of 0.66 compared to slope/estimates of 0.58. 
 The numbers for association with severe complications did not reach statistical 
significance with a p-value of 0.173 (CI 95%) and slope estimates of 0.24 and 0.21, 
extubated and not extubated respectively. 
 Significant findings from univariate regression were included in a stepwise 
multivariate regression, all were eliminated in that process. 
Hypothesis three (H3) 
 Hypothesis three (H3) assessed for a relationship between the use of morphine   
for the purpose of LCVP and outcomes for patients undergoing hepatic resection.  
Results for use of morphine are in Table 12. 
• Hypothesis three (H3): There is a relationship between the use of morphine for 
the purpose of LCVP and outcomes in patients undergoing hepatic resection. 
Hypothesis three was tested by univariate logistic regression and showed a 65% 
increase in superficial wound infection with an odds ratio of 1.65 (1.02-2.59, CI 95%), 
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and a 10% increase in deep wound infection or abscess with an odds ratio of 1.1 (0.75-
1.59, CI 95%).  The p-values were 0.035 and 0.618 respectively. 
 
 
Table 12.  Results for Use of Morphine 
Univariate Logistic Wound 
INF 
Odds Ratio (95% CI) p-value 
Morphine Used 1.65 (1.02-2.59) 0.035 
   
Univariate Logistic Int Abd Inf 
or Abc 
  
Morphine Used 1.1 (0.75-1.59) 0.618 
   
Univariate Logistic 90D 
Mortality 
  
Morphine Used 0.84 (0.36-1.77) 0.669 
   
Poisson Regression-Number 
of Complications 
Slope/ Estimates p-value 
Morphine Used 0.68  
Morphine Not Used 0.50 <.001 
   
Poisson Regression-Number 
of Severe Complications 
  
Morphine Used 0.25  
Morphine Not Used 0.19 0.011 
   
Multivariate Analysis Number 
of Complications 
Slopes P-Value 
Morphine 0.60 <.001 
 
Univariate regression for 90day mortality and use of morphine did not show 
statistical significance.  An odds ratio of 0.84 (0.36-1.77, CI 95%) suggests a 16% 
decrease which may be clinically significant. 
A Poisson regression analysis showed significance with the use of morphine 
(Slope/Estimate 0.50) versus no morphine (Slope/Estimate 0.68) with a p-value of <.001 
in any complications.  Additionally, mulitivariate analysis shows significance, p-value 
<.001, slope 0.60 in number of complications. 
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 Number of severe complications was also significantly associated with a 
protective effect with slope/estimates of 0.19 and 0.25 with morphine and no morphine 
respectively at a p-value of 0.003. 
Incidental Findings 
 Incidental findings from the analysis suggest that there is a relationship between 
gender and outcomes.  Univariate regression for wound infection showed a p-value of 
0.007 with an odds ratio of 0.53 (0.33-0.83, CI 95%) for female.  Univariate regression 
for deep wound infection or abscess was not significant as the p-value was 0.449 with 
an odds ratio of 0.88 (0.63-1.23, CI 95%) for female.  Univariate regression for 90day 
mortality showed a p-value of 0.013 with an odds ratio of 0.4 (0.18-0.8, CI 95%) for 
female.   
 The Poisson regression analysis for number of complications was significant at a 
p-value of <.001 and a slope/estimate at 0.56 compared to 0.70 for male.  Multivariate 
regression analysis demonstrated significance with a p-value of 0.010 and a slope of 
0.88 for female.  The Poisson regression analysis for severe complication was 
significant at a p-value of .002 and a slope/estimate at 0.20 compared to 0.26 for male.   
Finally, the multivariate analysis of female showed a significant relationship with number 
of complications (slope 0.88, p-value <.001).  The results for female or male are shown 
in Table 13.   
Further analysis of co-morbidities between the two groups using a Wilcox test 
showed a statistically significant difference between the groups with a p-value of <.001 
(Table 14).  These findings suggest that men have more co-morbidities than women in 
this population. 
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 Ninety-day mortality, (OR 7.74, CI 95%), Deep wound infections (OR 1.78, CI 
95%), were significantly associated with more than three segments of liver resected.   
 
Table 13. Results for Female vs Male  
Univariate Logistic Wound 
INF 
Odds Ratio (95% CI) p-value 
Female 0.53 (0.33-0.83) 0.007 
   
Univariate Logistic Int Abd 
Inf or Abc 
  
Female 0.88 (0.63-1.23) 0.449 
   
Univariate Logistic 90D 
Mortality 
  
Female 0.4 (0.18-0.8) 0.0.013 
   
Poisson Regression-
Number of Complications 
Slope/ Estimates p-value 
Male 0.70  
Female 0.56 <.001 
   
Poisson Regression-
Number of Severe 
Complications 
  
Male 0.26  
Female 0.20 0.002 
   
Multivariate Analysis 
Number of Complications 
Slopes P-Value 
Female .88 0.010 
 
Table 14. Results for Male vs Female Comorbidities 
  Female Male p-value 
Comorbidities     <.001 
1 1142 (92.6%) 1135 (88.3%)   
2 78 (6.3%) 137 (10.7%)   
3 13 (1.1%) 12 (0.9%)   
4 0 (0%) 1 (0.07%)   
Note: *P-value was generated using a Wilcox Test 
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Number of complications number of segments resected decreased by 52% for less than 
three segments and 9% for more than three segments over time (p-value <.001).  
Multivariate analysis showed a significant relationship between number of segments 
resected and number of complications (slopes 1.78, p-value <.001) and number of 
severe complications (slopes 2.14, p-value <.001).  Results for number of segments 
resected are shown in Table 15. 
Table 15. Results for Number of Segments 
Univariate Logistic Wound 
INF 
Odds Ratio (95% CI) p-value 
> = 3 Segments 1.23 (0.78-1.92) 0.363 
   
Univariate Logistic Int Abd 
Inf or Abc 
  
> = 3 Segments 1.78 (1.28-2.49) 0.001 
   
Univariate Logistic 90D 
Mortality 
  
> = 3 Segments 7.74 (3.58-19.29) <.001 
   
Poisson Regression-
Number of Complications 
Slope/ Estimates p-value 
< 3 Segments 0.48  
> = 3 Segments 0.91 <.001 
   
Poisson Regression-
Number of Severe 
Complications 
  
< 3 Segments 0.16  
> = 3 Segments 0.37 <.001 
   
Multivariate Analysis 
Number of Complications 
Slopes p-value 
Number of Segments 1.78 <.001 
   
Multivariate Analysis 
Number of Severe 
Complications 
  
Number of Segments 2.14 <.001 
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 Finally, total amount of fluid was statistically significant in all univariate, Poisson 
and multivariate regressions.  Results for total amount of fluids given are shown in 
Table 16. 
 
 
Table 16. Results for Total Amount of Fluids Given 
Univariate Logistic Wound 
INF 
Odds Ratio (95% CI) p-value 
Total Amount of Fluids 1.02 (1.01-1.03) 0.007 
Multivariate Logistic 
Wound INF 
  
Total Amount of Fluids 1.01 (1-1.02) 0.005 
   
Univariate Logistic Int Abd 
Inf or Abc 
  
Total Amount of Fluids 1.02 (1.01-1.03) <.001 
Multivariate Logistic Int 
Abd Inf or Abc 
  
Total Amount of Fluids 1.02 (1.01-1.02) <.001 
   
Univariate Logistic 90D 
Mortality 
  
Total Amount of Fluids 1.03 (1.02-1.04) <.001 
Multivariate Logistic 90D 
Mortality 
  
Total Amount of Fluids 1.03 (1.02-1.04) <.001 
   
Poisson Regression-
Number of Complications 
Slope/ Estimates p-value 
Total Amount of Fluids 1.01 <.001 
Multivariate Logistic 
Number of Complications 
  
Total Amount of Fluids 1.01 <.001 
   
Poisson Regression-
Number of Severe 
Complications 
  
Total Amount of Fluids 1.02 <.001 
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Multivariate Logistic 
Number of Severe 
Complications 
  
Total Amount of Fluids 1.02 <.001 
 
Chapter Summary 
 
 Chapter four presented the results from the statistical analysis of this study in an 
effort to assess for a relationship between changes in anesthetic technique and 
outcomes for patients undergoing hepatic resection.  The relationships with the use of a 
central venous catheter were analyzed using univariate, Poisson, and multivariate 
regression.  The findings revealed that there was a univariate statistical significance 
associated between the presence of central venous catheter and 90-day mortality as 
well as number of severe complications.  There was univariate significance suggesting 
patients who were extubated in the OR had more complications than those who were 
not. Use of morphine is associated with an increase in superficial wound infection as 
well as fewer number and severity of complications. 
 Additionally, the analyses incidentally demonstrated a relationship between 
gender, number of segments resected, and total amount of fluid given and outcomes. 
Chapter five will present and discuss the research findings as they pertain to the 
study objectives.  Additionally, the advantages and limitations of the study will be 
presented as well as any recommendations for future research. 
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Chapter 5: Discussion 
 
 
 
 Chapter five provides a summary of the study and an interpretation of the results 
described in Chapter Four.   
Summary and Overview of the Problem 
 
 Central venous pressure (CVP) has traditionally been considered a valid 
measurement of fluid status.  This measurement was incorporated into an anesthetic 
technique for patients undergoing hepatic resection at Memorial Sloan Cancer Center 
(MSKCC) in the mid 1990s in an effort to decrease blood loss.  This technique which 
involved keeping the CVP at less than five mmHg until the specimen was removed, in 
concert with the surgeon’s ability to control inflow into the liver, resulted in lower blood 
loss and a decrease in overall complications associated with this patient population at 
MSKCC.  Starting in the early 2000s, published clinical research began to emerge 
questioning the validity and accuracy of CVP as a predictor of fluid status.  In order to 
measure CVP, it is necessary to introduce a central venous catheter (CVC) in these 
patients.  There are many complications associated with insertion of a CVC.  In light of 
the findings that were increasingly being reported in the literature, the use of central 
venous catheters for the purpose of fluid management in was abandoned at MSKCC for 
patients undergoing hepatic resection.  This change in anesthetic practice was one of 
three that occurred between 2007 and 2016.  In addition to no longer introducing CVCs 
into patients for the purpose of fluid management, high doses of morphine were 
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abandoned in favor of the more predictable effects of sublingual nitroglycerin.  This 
allowed for early extubation of this patient population.  Prior to this change, patients 
were extubated in the PACU hours after the procedure had ended.  Finally, the use of 
dynamic measurements was gaining popularity around the same time the measurement 
of CVP was falling out of favor.  From 2014 on, patients undergoing hepatic resection 
were being managed with the use of devices that allowed for dynamic measurement of 
fluid status, and therefore were treated with goal directed fluid therapy (GDFT).  It is 
theorized that the evidence-based changes in the LCVP technique for patients 
undergoing hepatic resection at MSKCC lead to improved outcomes. 
Purpose of the Study 
The purpose of this study was to assess the relationship between changes in 
anesthetic technique over a 10-year period and outcomes in patients undergoing 
hepatic resection at MSKCC. 
Review of Theory and Research Question 
 Avedus Donabedian (Donabedian, 1978) introduced what became a widely 
accepted theory that measured quality of healthcare in 1966.  Donabedian described 
three constructs and their relationships; structure, process and outcome.  First, he 
DEFINED quality.  Donabedian concluded “Which of a multitude of possible dimensions 
and criteria are selected to define quality will, of course, have profound influence on the 
approaches and methods one employs in the assessment of medical care” 
(Donabedian, 2005).  The development of the theory involved a need to assess what 
needed needed to be assessed in order to determine a level of quality.  In doing so he 
settled on structure as defined by variables such as buildings, administrators, policies 
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and staff, process as defined by variables where the healthcare is being delivered to the 
patient such as procedures and techniques, and finally outcomes as defined as 
variables such as complications and length of stay. 
This study utilized two of Donabedian’s constructs, process and outcomes.  In 
this case the process is the use of CVC for the purposes of managing fluid status.  That 
process, in theory, has a relationship with outcomes, in this case, in the form of 
manifestation of complications in this patient population at the institution where the care 
was rendered.  The research question posed was: Is there a relationship between 
intraoperative insertion of CVC for the purpose of fluid management in hepatic resection 
and outcomes? 
Methodology 
 A non-randomized, non-experimental, retrospective, cohort design was used to 
explore the possibility of relationships between the variables of insertion of CVC, use of 
morphine, and fluid management with GDFT.  The hepatobiliary and anesthesia 
databases were queried for cases between January 1, 2007 and December 31, 2016.  
Descriptive statistics were used to characterize the variables and assess for 
relationships.  Univariate, Poisson, and multivariate regression analyses were 
conducted to distinguish the magnitude and significance of those relationships. 
Study Findings 
 Findings of the study were presented here regarding the hypothesis and 
research objectives.  Theoretical and practical ramifications were justified as evidenced 
in the review of the literature.  The study results suggest that there was an association 
between the presence of central venous catheter and 90-day mortality as well as severe 
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complications.  Multivariate analysis eliminated these relationships when all other 
significant finders were held constant.  Use of morphine is associated with an increase 
in wound infection and, conversely, improved outcomes regarding number and severity 
of complications. 
 Additionally, the analyses incidentally demonstrated a relationship between 
gender, number of segments, and total fluids given and outcomes. 
Hypotheses 
Three of the four hypotheses were supported. 
 
Hypothesis one (H1)  
Hypothesis one (H1) assessed for a relationship between the use of central 
venous catheters and outcomes for patients undergoing hepatic resection. 
• Hypothesis one (H1): There is a relationship between the use of central venous 
catheters and outcomes in patients undergoing hepatic resection. 
The findings suggest that presence of a CVC increases superficial, and deep 
wound infections.  There is a significant link to 90day mortality with CVC, over three-
fold.  This can be explained by many things, not the least of which is that the cases with 
CVC beyond the change in practice may have been those that fall into a more complex 
category.  It is also clear from the results that the incidence of complications have 
decreased over time.   
Hypothesis two (H2) 
Hypothesis two (H2) assessed for a relationship between the time of extubation and 
outcomes for patients undergoing hepatic resection.   
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• Hypothesis two (H2): There is a relationship between the time of extubation and 
outcomes in patients undergoing hepatic resection. 
 Clinical significance here shows a decrease in superficial and deep wound 
infections.  The apparent association with 90day mortality is notable and could possibly 
be explained by the fact that patients who remain intubated since the change in practice 
are those that have been through more complex procedures which are associated with 
poor outcomes.  Significance regarding number of complications is underscored by the 
improvement over time in both extubated and not extubated patients.  The findings 
suggest that not extubated patients tend to have fewer complications over all, but 
incidence of severe complications are at about the same in both groups. 
Hypothesis three (H3) 
 Hypothesis three (H3) assessed for a relationship between the use of morphine 
for the purpose of LCVP and outcomes for patients undergoing hepatic resection. 
• Hypothesis three (H3): There is a relationship between the use of morphine for 
the purpose of LCVP and outcomes in patients undergoing hepatic resection. 
 The findings suggest that use of morphine is associated with superficial wound 
infections but not deep wound infections.  This alone supports the change in practice to 
eliminate the use of morphine in favor of an alternative medication to lower CVP.  The 
relationship between not using morphine and number of complications shows a larger 
percent of improvement for the time under investigation, 50% versus 22% in patients 
where morphine was used.  Similarly, and also demonstrating significance was the 
relationship between not using morphine and severe complications.  The gap between 
using morphine and not using morphine was much closer, which may be explained by 
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overall decrease in severe complications over time.  Additionally, the amount of 
morphine given was associated with fewer sever complications.  It appears patients who 
received morphine have fewer complications as well as fewer severe complications than 
those who do not.  This contradicts the association with superficial wound infections.   
 An incidental finding suggested a relationship between the female gender and 
outcomes.  The results demonstrate that being female is associated with decreased 
incidence of wound infection, decreases chances for 90day mortality, decreased 
incidence of number of complications, and a decreased incidence of severe 
complications.  Further analysis showed that women in the population being 
investigated had fewer co-morbidities than their male counterparts.  It is also possible 
that women patients may have a separate primary cancer which generally means that 
the hepatic resection they may have had may have been less complex than those 
performed in male patients.  This would explain a lower incidence of complications in 
this population. 
 The relationship described regarding the number of segments resected, and total 
amount of fluids given, and outcomes is in line with published evidence.  Patients who 
have more complex procedures as well as those who receive more fluid tend to do 
worse than those who do not.  This is the rationale behind exploration of alternative 
approaches to treatment of patients who would require multiple segments and the 
increasing popularity of fluid optimization through GDFT.    
Contribution to the Literature 
 At this time, there are no studies that look specifically at the evolution of the 
LCVP technique and the potential relationships that may exists with outcomes in 
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patients undergoing hepatic resection.  Evidence based practice has evolved since the 
development of the LCVP technique.  With the intention of improving outcomes, the use 
of morphine to lower the CVP during these cases was abandoned, thus allowing for an 
earlier extubation and therefore, in theory, improved outcomes due to the elimination of 
complications associated with prolonged intubation and positive pressure ventilation.  
Marik et al’s (Marik  P. & Cavallazzi  R., 2013) contribution to the literature supported 
the utilization of dynamic measurements in favor of CVP and therefore the subsequent 
abandonment of the use of CVCs and their potential associated complications.  These 
changes in practice and their support based on these findings will contribute to the ever-
growing knowledge base providing evidence to improve practice in the patient 
population. 
Theoretical Implications 
 
Avedis Donabedian described a framework for assessing the quality of care. 
Donabedian used structure, process, and outcomes in his theory measuring the quality 
of healthcare  (Donabedian, 1978).  For the purpose of this dissertation, the constructs 
considered were process and outcomes.  The variables were whether a CVC was 
inserted, patients were extubated in the OR, whether morphine was used, how the fluid 
status was managed (process) and incidence complications associated with major 
organs, the gastrointestinal system as well as infection, hemorrhage, wound breakdown 
and length of stay (outcome).  
 The change in practice the eliminated the use of CVCs in this patient population 
theoretically decreased the incidence of complications associated with CVCs.  The 
results support this with the relationship between CVC and 90day mortality (OR 3.34, p-
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value <.001).  There was also a significant relationship between the use of CVC and 
severe complications.  Regarding use of CVC, it would appear that a change in process 
has improved outcomes. 
 The results regarding the extubation of patients in the OR are somewhat 
conflicting.  Patients who were extubated reached statistical significance only in the 
number of complications category.  The results suggest that patients who are extubated 
in the OR are slightly more likely to have any complication than those who were not 
extubated.  These findings are in conflict with the clinically significant results that 
suggest extubating a patient in the OR is associated with improved outcomes over the 
time of the investigation.  
 The use of morphine was associate increased wound infections and any 
complications but a slight improvement regarding severe complications.  These findings 
suggest that the change in practice was arguably supported and therefore in line with 
improved patient outcomes. 
Donabedian thought that process had specific importance in measuring quality.  
In this case the quality is measured by complications associated with anesthetic 
practice in patients undergoing hepatic resection.  Donabedian believed that focus 
should be on improving outcomes by way of improving process. However, not all 
improvements in process significantly affect the outcome (Harolds, 2015).  What is 
supported in this investigation is that changes in process can have a relationship with 
outcomes but not all changes in process, even those ostensibly founded on evidence, 
will necessarily influence outcomes in the intended, or extent, intended. 
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Practical Implications 
 The results from this study have practical implications for anesthesia care 
providers who care for patients undergoing hepatic resection.  The LCVP technique was 
developed to decrease blood loss in this patient population.  The evidence showed that 
controlling CVP with the use of morphine during hepatic resection was a safe and 
effective practice (Cunningham et al., 1994; Melendez et al., 1998).  With the innovation 
of new measurements for assessing fluid status, specifically SVV, SPV,PPV, and PVI 
and evidence in the literature that the measurement of CVP was no longer considered 
accurate, the LCVP technique was modified over time (Marik et al., 2008, 2009; 
Marik  P. & Cavallazzi  R., 2013; Frédéric Michard, 2005).   
This current study demonstrated a significant relationship between presence of a 
CVC and 90day mortality and severe complications.  Practice at MSKCC no longer 
involves using the CVP measurement for the LCVP technique in favor of use of dynamic 
measurements.  The results from this study support this change in practice.  The 
clinically significant findings suggest that presence of a CVC may be associated with 
increased wound infection, deep wound infection or abscess, 15% and 10% 
respectively.  Presently at MSKCC, case complexity drives the decision to use or not 
use a CVC.  One could argue that presence of the CVC is associated with poor 
outcomes due to the fact that these procedures tend to be more complicated, lose more 
blood and therefore are prone to complications (Kingham et al., 2015). 
This may be the case with this population, however, avoiding the use of CVC when not 
necessary appears to be supported by the findings of this study. 
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 Extubation of patients undergoing hepatic resection was associated with a 
clinically significant decrease in infections both superficial and deep wound or abscess.  
Overall complications over time decreased, which is a positive finding.  However, it 
appears that early extubation does not show the same improvement in number of 
complications and is on par with severe complications with those patients that were not 
extubated.  These findings support the hypothesis that there is a relationship, but not in 
the manner in which it was intended.  The evidence in the literature supporting early 
extubation and limited mechanical ventilation may still take precedence over these 
findings (Nobili et al., 2012). 
 Use of morphine for the purpose of lowering the CVP shows a relationship with 
increase in superficial wound infections.  However, the results from the Poisson 
regression suggest that the association between morphine and number of complications 
as well as severe complications improved over time, and not using morphine showed 
better results.  The practice of using morphine not only fell out of favor for hepatic 
resections at MSKCC but was virtually eliminated from all practice unless a patient was 
allergic to the alternatives.  The opioid it was replaced with, for the most part, was 
hydromorphone.  Interestingly, at the time of this writing, there is a severe national 
shortage of hydromorphone and morphine has been restocked as the opioid of choice 
until such time that stocks of hydromorphone have been replenished.  However, the 
indication for the use of morphine at this time is purely for analgesia. 
Limitations 
 Disadvantages of a retrospective study design include limited control of the 
investigator over the approach to data gathering and the nature and quality of the 
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baseline measurements.  Additionally, it is difficult to account for input failures, various 
forms of bias, maturation and practice changes.   The largest limitation of this 
investigation is that it is not possible to infer causality from the results.  Additionally, the 
data was incomplete, sample size does impact the ability to address the research 
question(s) (Hully et al., 2013).   
Threats to Internal Validity 
 
“With quasi-experiments and correlational studies, there are competing 
explanations, which are sometimes called threats to internal validity”(Polit, 2006).  
Selection bias in an unavoidable threat to internal validity in retrospective study design.  
One could argue that patients undergoing hepatic resection are predisposed to unique 
categorical complications.  If a population is inherently likely to demonstrate a 
characteristic, variables that influence these outcomes may be impossible to account 
for. 
Historical threats are occurrence of events concurrent with variables under 
investigation that can affect the outcome (Polit, 2006).  In this case, an example of a 
historical threat is a change in surgical technique or patient selection that may have had 
an influence on the outcomes that were being measured.  If the surgeons improved their 
technique or eliminated a particular procedure due to higher risk of poor outcomes, this 
would have an effect on validity of the findings. 
Retrospective study design necessitates the investigators inclusion of alternative 
explanations for the findings.  Rival variables that were not included in the analysis 
cannot be excluded as potential confounders leading to the findings (Polit, 2006). 
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Threats to External Validity 
 
 “External validity concerns inferences about whether relationships found for study 
participants might hold true for different people, conditions, and settings”(Polit, 2006). 
The population under investigation is narrow, that is, patients undergoing hepatic 
resection.  The practices at one institution may not necessarily be applicable to other 
those at other institutions.  It is also not known, in this case, how many other institutions 
are practicing the same LCVP technique that was first described by Cunningham et al. 
(1991) and later validated as safe and effective by Melendez et al. (1998) (Cunningham 
et al., 1994; Melendez et al., 1998).  It is also unknown to what degree, if any, the LCVP 
technique at other institutions has evolved in response to evidence in the literature.  It is 
safe to say, only, that the findings reported in this investigation are applicable to the 
population investigated at the institution where the study was conducted. 
Conclusions and Recommendations for Future Research 
 This investigation examined relationships between changes in anesthetic 
technique in patients undergoing hepatic resection and outcomes.  The study revealed 
a relationship between presence of CVC and 90day mortality and presence of CVC and 
severe complications.  Regarding extubation of the patient in the OR, there was a 
clinically significant association with decrease in infection rates and a mildly significant 
association between extubation in the OR and less protective effects when compared to 
extubation in the post anesthesia care unit.  Use of morphine for the purposes of 
lowering the CVP fell out of favor during the time period being investigated.  This study 
revealed that use of morphine for this purpose was associated with an increase in 
wound infection.  There was also a relationship revealed between use of morphine and 
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any complications.  This relationship was also demonstrated with multivariate 
regression.  Conversely, the use of morphine was associated with fewer severe 
complication, this may be explained by alternative approaches to LCVP technique in 
these cases. 
In 2015, Kingham et al. (2015) attributed improvements in outcomes to better 
patient selection, improved surgical techniques and utilization of alternative therapies 
(Kingham et al., 2015).  The purpose of this study was to assess whether changes in 
anesthesia practice over an updated timeframe would demonstrate a relationship with 
outcomes in the same patient population.  Further study might take into account more 
variables or a narrower approach considering the wide spectrum of cases assessed 
here.  Additionally, it would be interesting to know if the use of GDFT has a relationship 
with outcomes in the timeframe or going forward.  It is possible that other variables 
associated with anesthetic technique may have influenced the results.  Of note, the 
elimination of a number of cases due to missing data may have affected the findings.  
Going forward, research assessing the impact of anesthetic technique in this population 
should advance with more consistent data collection.  At this time, at MSKCC all data is 
maintained electronically, as a result, prospective research will most certainly 
demonstrate improved internal and external validity. 
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